Pharmafile Logo
Pharmafocus logo
Advanced Search
shutterstock_138095450

Novartis follows Pfizer’s lead, pledges no price hikes in 2018

July 18, 2018
Research and Development, Sales and Marketing Novartis, Pfizer, President trump, Trump, US, pharma

Following US pharma giant Pfizer’s clash with President Donald Trump after it was called out on Twitter for hiking the …

News
administration_building_mclean_hospital_belmont_ma

Researchers develop algorithm able to identify antidepressant suitability

July 18, 2018
Research and Development McLean, algorithm, antidepressants, research

A study published by researchers at McLean Hospital in Belmont, Massachusetts has led to the development of a statistical algorithm …

News
humira_abbott__4

AbbVie and Mylan reach US marketing agreement for Humira biosimilar

July 18, 2018
Research and Development, Sales and Marketing AbbVie, Humira, Mylan, US, pharma

AbbVie and Mylan have announced that they have both signed a licensing agreement for the former’s proposed biosimilar version of …

News
nazneen-rahman-credit-the-royal-marsden-embed

Renowned cancer researcher leaves ICR over bullying allegations

July 17, 2018
Research and Development

Leading geneticist and cancer researcher, Nazneen Rahman CBE, has resigned from her position as head of Genetics and Epidemiology at …

News
david_horn_solomon

Silence Therapeutics appoints ex-Akari CEO in top position

July 17, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akari, CEO, Sanofi, Silence Therapeutics, zealand

Silence Therapeutics has appointed Dr David Horn Solomon as its new Chief Executive Officer (CEO), effective immediately. Solomon will head …

Appointment
diabetes-777001_960_720

Researchers successfully minimise diabetes drug side-effects in animal models

July 17, 2018
Manufacturing and Production, Research and Development FDA, diabetes, pharma, type 2 diabetes

Researchers at the University of Pennsylvania and Syracuse University have modified a key ingredient of current diabetes drugs to produce …

News

Roche flu drug proves efficacy at Phase 3, but enough to beat Tamiflu generics?

July 17, 2018
Manufacturing and Production, Research and Development Roche, Tamiflu, baloxavir marboxil, flu, influenza, pharma

Roche is celebrating the news that its investigational influenza drug baloxavir marboxil performed well at Phase 3, meeting its primary …

News
jj_sign_on_wall

J&J stops Invokana trial early after success in kidney disease and type 2 diabetes

July 17, 2018
Manufacturing and Production, Research and Development J&J, JJ, Janssen, Johnson & Johnson, invokana, kidney disease, pharma, renal, type 2 diabetesm diabetes

Johnson & Johnson and research arm Janssen have taken the decision to terminate a Phase 3 trial evaluating the efficacy …

News
5204602349_c87b204860_z

FDA cautions consumers on fake warning letter scam

July 17, 2018
Manufacturing and Production FDA, fake, letter, scam, warning

The FDA has warned that criminals have been targeting customers who bought medicines online or over the phone with “official-looking, …

News

CRISPR gene editing may frequently cause undetected genetic damage

July 17, 2018
Manufacturing and Production DNA, crispr, gene editing, genetic damage

Scientists studying the gene editing technology CRISPR-Cas9 have discovered the technique appears to frequently cause genetic damage that may slip …

News
489px-trump_executive_michael_cohen_013_cropped

Senate claims Novartis misled public on Trump lawyer deal

July 16, 2018
Sales and Marketing Novartis, Senate, Trump, United States, deal

A report released by the United States Senate has found that Novartis’ relationship with Donald Trump’s long-time lawyer Michael Cohen …

News
patient_graphic

Recruitment and retention: How can we do better?

July 16, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing clinical trials, feature, patient recruitment, patients, pharma

In pharma R&D, data is king, but consistent struggles with patient retention is undermining the integrity of clinical findings. Matt …

Feature

FDA expands Pfizer and Astellas’ Xtandi into castration-resistant prostate cancer

July 16, 2018
Sales and Marketing Astellas, Cancer, FDA, Pfizer, US, Xtandi, pharma, prostate cancer

Astellas and Pfizer have revealed that their androgen receptor inhibitor Xtandi (enzalutamide) has received approval from the FDA to expand …

News
shutterstock

FDA approves first smallpox therapy to defend against bioterrorism

July 16, 2018
Sales and Marketing FDA, pharma, smallpox

The FDA has announced that it has awarded marketing authorisation to SIGA Technologies’ TPOXX (tecovirimat) in the first approval of …

News
medicinal_cannabis_uk_review

European cannabis market set to be worth €115.7 billion by 2028

July 16, 2018
Sales and Marketing Europe, Legislation, cannabis, medicinal marijuana

The European cannabis market is set to be worth €115.7 billion by 2028, according to a report released by the …

News

Indivior shares soar as US judge rules against Dr Reddy

July 16, 2018
Sales and Marketing

Shares in the London listed addiction specialist Indivior surged in price today, as the Indian pharmaceutical company Dr Reddy’s Laboratories …

News
gsk_boronia_australia

GSK confirms £250m deal to sell experimental drug to Dermavent Sciences

July 13, 2018
Medical Communications Dermavent, GSK, Roivant, tapinarof

British company GlaxoSmithKline has announced that it will sell the rights to its experimental dermatology drug, tapinarof, to Roivant Sciences’ …

News
johnson_and_johnson_jj

J&J ordered to pay $4.68 billion to talc-powder plaintiffs

July 13, 2018
Medical Communications J&J, JJ, Johnson and Johnson, legal, talc powder

A Missouri jury has ordered the New Jersey-based healthcare company Johnson and Johnson to pay $4.69 billion to 22 women …

News

Alvogen court case causes Nevada Judge to halt execution

July 13, 2018
Medical Communications Alvogen, Nevada, court, execution, lethal injection

A Nevada Judge has temporarily prevented the use of the sedative midazolam, in the execution of the twice convicted killer …

News
takeda_usa_pharmaceuticals_u

Takeda’s Ninlaro clears Phase 3 endpoint as maintenance therapy in multiple myeloma

July 12, 2018
Medical Communications, Research and Development Ninlaro, Takeda, multiple myeloma, pharma

After making headlines with its mammoth deal to acquire Shire earlier this year, Takeda has emerged with new Phase 3 …

News
The Gateway to Local Adoption Series

Latest content

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026